Skip to Content

2nd Neoantigen Summit

Start Date:
Tuesday, 14 November, 2017
End Date:
Thursday, 16 November, 2017 5:00pm
Internal Medicine

The Neoantigen Summit is the dedicated end-to-end industry focused meeting ensuring the supercharging of immunotherapies and cancer vaccines to bring truly individualized therapies to patients in need. Hear the latest clinical updates from pioneers in this field and define your commercialization roadmap to achieve future regulatory success, scale manufacturing and ensure enhanced clinical efficacy. In such a rapidly evolving field, this is the premier platform to benchmark against the industry and network with the crème de la crème of neoantigen therapy developers.

Join us as the industry seeks to demonstrate significant clinical proof of concept and ensure you and the key stakeholders can make the scientific, clinical and commercial decisions needed to bring these therapies market. URL:Brochure: Only - Vendor: USD 3099, Conference + 1 Workshop - Vendor: USD 3698, Conference + 2 Workshops - Vendor: USD 4297, Workshop Only - Vendor: USD 899, Conference Only - Industry: USD 2699, Conference + 1 Workshop - Industry: USD 3298, Conference + 2 Workshops - Industry: USD 3897, Workshop Only - Industry: USD 699Speakers: Robert Ang (Neon Therapeutics), David Kaufman (Merck), Jim Johnston (Amgen), Harpreet Singh (Immatics Biotechnologies), Paul Robbins (NCI)


Hilton Boston,
2 Forbes Road,
United States

Organizer Details

Conference organized by Hanson Wade


Medical conference data provided by Meetings4Docs | Report a problem

Image Gallery